Clinical Trial Update: Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and memory effects of PYM50028 in individuals with mild Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PYM50028

Snippet

Sponsor: Phytopharm | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED